This invention provides compounds of formula I, having the structure
##STR1##
wherein R1, R4, A, and Z are as defined in the specification,
or a pharmaceutically acceptable salt thereof, that are useful in treating metabolic
disorders mediated by insulin resistance or hyperglycemia.
